The high expense of healthcare in America (US) and elsewhere can limit the power of people to find the money for and adhere to remedy selections. Therefore, by their respective associations/bodies, companies can champion plan proposals that advocate a cap on out-of-pocket investing on all prescription medicines based on the income and socioeconomic